Stocks
Iovance Biotherapeutics (IOVA) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -55.1% | -79.2% | -76.0% | -52.4% | -56.0% | -49.0% | ||
| Changes by years, y/y, % | -16pp | -24pp | +3pp | +24pp | -4pp | +7.2% | |||
Iovance Biotherapeutics. ROE, %
Iovance Biotherapeutics. ROE, changes, pp
Iovance Biotherapeutics (IOVA) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | -48.9% | -55.8% | -56.6% | -56.0% | -49.0% | -49.0% | |
| Changes by years, y/y, % | +17pp | +1pp | -4pp | -4pp | 0pp | |||
| Changes by quarters, q/q, % | +4pp | -7pp | -1pp | +1pp | +7pp | |||
